• LAST PRICE
    1.4800
  • TODAY'S CHANGE (%)
    Trending Up0.0300 (2.0690%)
  • Bid / Lots
    1.4300/ 1
  • Ask / Lots
    1.4500/ 3
  • Open / Previous Close
    1.4700 / 1.4500
  • Day Range
    Low 1.4201
    High 1.5195
  • 52 Week Range
    Low 0.9172
    High 9.5400
  • Volume
    378,806
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 1.45
TimeVolumePTPI
09:32 ET65461.4289
09:34 ET13001.45
09:36 ET15601.434
09:38 ET6001.4433
09:39 ET44401.4201
09:41 ET65001.44
09:43 ET28911.43
09:45 ET14001.46
09:48 ET24551.4403
09:50 ET29071.4314
09:52 ET1001.4393
09:54 ET5501.43
09:56 ET3081.44
09:57 ET10501.45
09:59 ET25241.451
10:01 ET2751.455
10:03 ET56441.46
10:06 ET3001.46
10:08 ET2501.4599
10:10 ET12041.46
10:12 ET1851.4594
10:14 ET22001.47
10:15 ET28181.45
10:21 ET6881.47
10:24 ET106781.47
10:26 ET35741.45
10:28 ET1501.46
10:30 ET29501.45
10:33 ET7421.45
10:35 ET61001.451
10:37 ET60001.4682
10:39 ET26001.45
10:42 ET7001.46
10:44 ET10391.46
10:48 ET2001.46
10:51 ET35001.4501
10:55 ET1001.455
10:57 ET3001.45
11:00 ET8301.46
11:02 ET5001.452
11:04 ET1001.4501
11:08 ET7001.4555
11:09 ET19001.458
11:18 ET1501.455
11:20 ET7331.45
11:22 ET4481.45
11:29 ET2701.46
11:36 ET13001.4602
11:38 ET49311.4601
11:44 ET7001.4601
11:45 ET6001.46
11:49 ET1001.4601
12:00 ET1991.465
12:14 ET22641.46
12:20 ET1001.46
12:25 ET122931.46
12:27 ET11001.4601
12:30 ET1001.465
12:32 ET79061.48
12:34 ET3481.49
12:38 ET1001.48
12:41 ET11091.48
12:45 ET3501.4797
12:48 ET7001.47
12:50 ET48011.48
12:57 ET34741.482
01:01 ET4001.4899
01:08 ET19751.495
01:10 ET3001.4901
01:12 ET149551.4998
01:14 ET32621.4985
01:15 ET14751.4968
01:17 ET5001.495
01:19 ET106031.48
01:21 ET1001.49
01:24 ET15501.4901
01:26 ET40491.49
01:28 ET1251.495
01:30 ET147811.51
01:32 ET46361.51
01:33 ET148091.51
01:35 ET37601.5099
01:39 ET6001.51
01:42 ET2001.5
01:44 ET1001.5039
01:48 ET1001.505
01:50 ET6001.5008
01:51 ET10001.5097
01:53 ET5001.5001
01:55 ET14001.4901
01:57 ET5001.4924
02:00 ET1651.49
02:02 ET10001.495
02:04 ET10901.5
02:06 ET70351.4706
02:08 ET21051.4722
02:09 ET14621.498
02:11 ET4851.495
02:13 ET3001.49
02:15 ET6001.49
02:20 ET11001.47
02:26 ET52291.465
02:27 ET17101.46
02:31 ET17001.4739
02:33 ET2001.48
02:36 ET2391.4899
02:38 ET25821.4601
02:40 ET8001.4799
02:42 ET10001.47
02:44 ET10001.47
02:45 ET28001.46
02:47 ET1501.4601
02:49 ET10001.47
02:51 ET11001.46
02:54 ET16971.462
02:58 ET100001.4666
03:00 ET8111.4899
03:02 ET1551.4899
03:03 ET11001.4803
03:07 ET23001.49
03:09 ET5001.4875
03:12 ET36001.49
03:14 ET9001.49
03:16 ET87351.49
03:18 ET1001.49
03:20 ET40001.4899
03:25 ET1231.49
03:32 ET155841.4901
03:36 ET34001.49
03:39 ET6461.49
03:45 ET1951.48
03:52 ET102051.475
03:56 ET112441.48
03:59 ET13561.48
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesPTPI
Petros Pharmaceuticals Inc
3.3M
-0.2x
---
United StatesTCBP
TC BioPharm Ltd
1.8M
0.0x
---
United StatesSTMM
Stemcell Holdings Inc
1.6M
750.0x
---
United StatesPULM
Pulmatrix Inc
6.4M
-0.4x
---
United StatesKA
Kineta Inc
5.8M
-0.4x
---
United StatesGBIM
Globeimmune Inc
10.0
0.0x
---
As of 2024-03-29

Company Information

Petros Pharmaceuticals, Inc. is a pharmaceutical company. The Company is focused on men’s health therapeutics with a full range of commercial capabilities including sales, marketing, regulatory and medical affairs, finance, trade relations, pharmacovigilance, market access relations, manufacturing, and distribution. It commercializes therapeutics for men's health issues, such as endothelial dysfunction, psychosexual and psychosocial ailments, hormone health, and substance-use disorders. It also commercializes and develops Stendra, a PDE-5 inhibitor prescription medication for the treatment of erectile dysfunction (ED). It also markets its own line of ED products in the form of vacuum erection device products through its subsidiaries, Timm Medical and PTV. In addition to ED products, it has a global license (the Hybrid License) to develop and commercialize H100, a novel and patented topical formulation candidate for the treatment of acute Peyronies disease.

Contact Information

Headquarters
1185 Avenue Of The Americas 3Rd Floor, Suite 570NEW YORK, NY, United States 10036
Phone
973-242-0005
Fax
302-655-5049

Executives

Executive Chairman of the Board
John Shulman
President, Chief Commercial Officer
Fady Boctor
Independent Vice Chairman of the Board
Joshua Silverman
Chief Accounting Officer, Vice President - Finance
Mitchell Arnold
Independent Director
Bruce Bernstein

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$3.3M
Revenue (TTM)
$7.0M
Shares Outstanding
2.2M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-6.05
Book Value
$8.03
P/E Ratio
-0.2x
Price/Sales (TTM)
0.5
Price/Cash Flow (TTM)
---
Operating Margin
-181.54%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.